Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting crawled date : 2021 - 10 - 01 save search
XP Inc. Announces Results of Annual General Meeting Held on October 1, 2021
Published: 2021-10-01 (Crawled : 23:00) - globenewswire.com
XP | $20.65 0.39% 0.39% 4.6M
|
Technology Services
| Email alert
Add to watchlist
results
Mereo BioPharma and Ultragenyx Present Data from the Phase 2b ASTEROID Study of UX143 (setrusumab) in Osteogenesis Imperfecta (OI) at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting
Published: 2021-10-01 (Crawled : 21:00) - globenewswire.com
MREO | $2.785 0.18% 0.18% 570K
|
Health Technology
| Email alert
Add to watchlist
RARE F | $44.26 -1.88% -1.92% 670K
|
Health Technology
| Email alert
Add to watchlist
phase 2 biopharma bone phase 2b research
Aravive to Present New Preliminary Data from Phase 1b Trial Evaluating AVB-500 in Clear Cell Renal Cell Carcinoma at 2021 Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 15:00) - biospace.com/
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 1.34%
H: 1.86%
C: -2.39%
immunotherapy phase 1 renal therapy cancer trial phase 1b phase 2b cell carcinoma
CRISPR Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
CRSP | News M | $55.66 -1.33% -1.35% 910K
|
Health Technology
|
| O: -0.16%
H: 0.57%
C: -0.41%
crispr immunotherapy therapy cancer preclinical pre-clinical
Oncorus to Present Initial Data from its Ongoing Phase 1 Clinical Trial of ONCR-177 at the Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: -0.11%
H: 1.61%
C: 0.21%
immunotherapy ongoing phase 1 therapy cancer trial
ALX Oncology Announces Four Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
ALXO M | $16.24 4.77% 4.56% 440K
|
Commercial Services
|
| O: -0.31%
H: 1.71%
C: 1.05%
presentation immunotherapy therapy cancer
Atreca Announces Poster Presentations at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
BCEL P | $0.08 0.0% 160K
|
Health Technology
|
| O: -1.12%
H: 2.11%
C: -0.65%
presentation immunotherapy therapy cancer
Tempest Announces Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
TPST | $3.43 0.29% 0.29% 650K
|
Manufacturing
|
| O: 0.48%
H: 4.59%
C: 3.85%
presentation immunotherapy pest therapy cancer
CymaBay Therapeutics Announces Presentations at The Liver Meeting® 2021
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 0.27%
H: 1.37%
C: 1.37%
presentation liver therapeutics
Ocuphire’s Clinical Phase 2b Oral Drug Candidate APX3330 for Retina to be Featured at the OIS Retina@ASRS and ASRS 2021 Annual Meeting
Published: 2021-10-01 (Crawled : 14:00) - biospace.com/
OCUP | News | $1.52 -1.3% -1.32% 90K
|
Health Technology
|
| O: -0.19%
H: 2.14%
C: 0.97%
phase 2 retina drug phase 2b apx3330
NextCure to Give Three Presentations at Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 14:00) - biospace.com/
NXTC | $1.43 -6.54% -6.99% 180K
|
Health Technology
|
| O: 3.86%
H: 11.57%
C: 8.0%
presentation immunotherapy therapy cancer
Potential Response Predictors to IMV’s Lead Compound in the DeCidE Clinical Study in Patients with Advanced, Recurrent Ovarian Cancer to be Presented at SITC Annual Meeting
Published: 2021-10-01 (Crawled : 14:00) - biospace.com/
IMV | $0.8225 -2.74% 45K
|
Health Technology
|
| O: 1.2%
H: 2.98%
C: 1.79%
potential cancer ovarian cancer
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapies Across Multiple Solid Tumors and Treatment Settings at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:00) - biospace.com/
IOVA M | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: -0.69%
H: 9.02%
C: 7.59%
treatment immunotherapy solid tumors therapy cancer iot
Shattuck Labs to Present Clinical Data on SL-172154 and SL-279252 and Preclinical Data on SL-9258 at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-10-01 (Crawled : 14:00) - globenewswire.com
STTK | $9.87 4.0% 3.85% 230K
|
Health Technology
|
| O: 0.05%
H: 5.05%
C: 3.38%
immunotherapy therapy cancer preclinical pre-clinical
Xencor to Present Data from the Phase 1 Study of Vudalimab (XmAb®717) and Four Research Programs at the SITC Annual Meeting
Published: 2021-10-01 (Crawled : 13:00) - biospace.com/
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
phase 1 research
Ikena Oncology to Present a Trial-in-Progress Update, Translational Data, and Indication Selection Methodology for Novel AHR Inhibition Program at the 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 13:00) - biospace.com/
IKNA | $1.31 -2.96% -3.05% 150K
|
Manufacturing
|
| O: 1.19%
H: 4.54%
C: 1.64%
immunotherapy therapy cancer trial
Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - prnewswire.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: -2.62%
immunotherapy therapy cancer
Celyad Oncology to Present New Data on Allogeneic CAR T Therapy Program at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -4.47%
immunotherapy therapy cancer car-t
Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021)
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: 3.86%
H: 0.57%
C: 0.57%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -1.01%
H: 0.42%
C: -0.23%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -8.06%
H: 3.28%
C: 1.51%
immunotherapy therapy cancer solid tumors
aTyr Pharma Announces Poster Presentation at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -0.55%
H: 0.74%
C: -5.2%
presentation immunotherapy therapy cancer pharma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.